Skip to main content

Table 2 Univariate analysis to identify risk factors associated with the recurrence of HCC patients with staging I–II

From: Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study

Variables

Statistics

HR 95%CI

P Value

Age (years)

 ≤ 60

351 (70.766%)

1.0

 

 > 60

145 (29.234%)

0.742 (0.540, 1.020)

0.06634

Sex

 Male

394 (79.435%)

1.0

 

 Female

102 (20.565%)

0.638 (0.435, 0.937)

0.02180

Smoking

 No

316 (63.710%)

1.0

 

 Yes

180 (36.290%)

1.346 (1.016, 1.783)

0.03872

Drinking

 No

387 (78.024%)

1.0

 

 Yes

109 (21.976%)

1.208 (0.878, 1.662)

0.24598

HCC family history

 No

436 (87.903%)

1.0

 

 Yes

60 (12.097%)

1.248 (0.837, 1.861)

0.27741

HBsAg

 Negative

71 (14.609%)

1.0

 

 Positive

415 (85.391%)

1.627 (1.024, 2.583)

0.03917

ALT (U/L)

30.00 (8.00–605.00)

1.002 (0.999, 1.004)

0.20455

AST (U/L)

30.00 (12.00–386.00)

1.005 (1.001, 1.008)

0.00610

ALP (U/L)

93.767 ± 47.817

1.006 (1.004, 1.009)

< 0.00001

GLR

30.61 (3.00–636.84)

1.003 (1.002, 1.004)

< 0.00001

HB (g/L)

133.773 ± 17.953

1.011 (1.003, 1.019)

0.01016

PLT (10^9/L)

137.879 ± 61.046

1.001 (0.998, 1.003)

0.62340

AFP (ng/ml)

 ≤ 20

214 (45.053%)

1.0

 

 > 20

261 (54.947%)

1.605 (1.199, 2.150)

0.00149

Child–Pugh class

 A

472 (95.161%)

1.0

 

 B

24 (4.839%)

1.050 (0.572, 1.930)

0.87432

Differentiation

 Well-moderate

426 (89.684%)

1.0

 

 Poor

49 (10.316%)

0.932 (0.586, 1.484)

0.76792

Lymphovascular invasion

 No

392 (79.032%)

1.0

 

 Yes

104 (20.968%)

2.337 (1.705, 3.204)

< 0.00001

ASA

I

51 (10.324%)

1.0

 

II

408 (82.591%)

1.007 (0.638, 1.587)

0.97718

III

35 (7.085%)

0.947 (0.482, 1.864)

0.87588

Operation time (min)

161.371 ± 58.525

1.002 (1.000, 1.005)

0.03542

Urine volume (ml)

300.00(0.00–2150.00)

1.000 (1.000, 1.001)

0.39094

Blooding volume (ml)

300.00 (5.00–5000.00)

1.000 (1.000, 1.000)

0.18443

Allogeneic blood

 No

424 (86.004%)

1.0

 

 Yes

69 (13.996%)

1.542 (1.070, 2.223)

0.02024

Tumor number

 Single

465 (93.750%)

1.0

 

 Mutiple

31 (6.250%)

1.885 (1.127, 3.150)

0.01565

TNM

 I

364 (73.387%)

1.0

 

 II

132 (26.613%)

2.443 (1.813, 3.292)

< 0.00001

Tumor size (cm)

 ≤ 5

332 (66.935%)

1.0

 

 > 5

164 (33.065%)

1.633 (1.229, 2.170)

0.00071

  1. Data presented were mean ± SD, median (Min–Max), or N (%); HR and 95% CI